简体中文 | 繁体中文 | English
Home | About CMS | Business | Portfolio | News Center | Investor Relations | Corporate Culture | Human Resources | Contact Us
  Current Page:Home > About CMS > History
About CMS
 
 
Corporate Profile
- Direct Academic Orientated Promotion Model
- Agency Promotion Model
Chairman's Statement
Corporate Vision
Corporate Governance
Operation Overview
History
Awards
 
History


 January 1995

 Chairman founded the Group

 2002

 Entered into exclusive agreements to promote and sell Deanxit and Ursofalk in the PRC.

 October 2006

 Obtained the exclusive rights to promote and sell Augentropfen Stulln Mono
 Eye-drops in the PRC.

 December 2006

 Obtained the exclusive rights to promote and sell GanFuLe in the PRC.

 June 2007

 Listed on AIM (the Alternative Investment Market operated by the London Stock Exchange plc)

 March 2008

 Obtained the exclusive rights in the PRC to promote and sell XinHuoSu and Cystistat.

 June 2008

 Awarded the first “Leading Enterprises in Independent Innovative Industry”
 by the Shenzhen government.

 September 2008

 Obtained the exclusive rights to promote and sell Salofalk in the PRC.

 October 2008

 Included in the 2008 Forbes list of “Asia’s Best 200 Enterprises Under a Billion.”

 December 2009

 Named one of the “Top 100 Enterprises in Shenzhen”.

 January 2010

 Included in the 2010 Forbes list of “China’s Best Up-and-Coming Business”.

 Obtained the right to promote and sell one shipment of Exacin in the PRC.

 February 2010

 Obtained the exclusive rights to promote and sell Bioflor in the PRC.

 September 2010  The company stocks transferred from AIM to Main Board Market in Hong Kong
 December 2010  Named one of the “Top 100 Enterprises in Shenzhen”.
 February 2011  Included in the 2011 Forbes list of “China’s Best Up-and-Coming Business”.
 April 2011  Acquired Tianjin Precede Medical Trade Development Co., Ltd.
 (which has been officially renamed Tianjin Kangzhe Pharmaceutical
 Technology Development Co., Ltd.on 24 October 2011)
 May 2011  Acquired 51% equity interests of Guangming Pharmaceutical Co., Ltd.
 (which has been officially renamed Guangxi Kangzhe Guangming Pharmaceutical Co., Ltd.
 on 10 October 2011)
 December 2011  Named one of the “Top 100 Enterprises in Shenzhen”.
 January 2012  Included in the 2012 Forbes list of “China’s Best Up-and-Coming Business”.

China Medical System Holdings Limited Copyright: Guangdong ICP NO.06017265
Internet Drug Information Service Certificate NO:(Guangdong)-Non-operation-2011-0090